Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report)'s stock price reached a new 52-week high on Tuesday . The company traded as high as $26.77 and last traded at $26.62, with a volume of 271863 shares. The stock had previously closed at $25.54.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on PAHC shares. BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 target price for the company in a report on Monday, June 16th. BNP Paribas raised Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. Morgan Stanley set a $26.00 target price on Phibro Animal Health and gave the stock an "equal weight" rating in a research note on Wednesday, June 25th. Finally, Wall Street Zen raised Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Two analysts have rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $21.80.
Get Our Latest Research Report on Phibro Animal Health
Phibro Animal Health Stock Performance
The stock has a market capitalization of $1.13 billion, a PE ratio of 35.89, a price-to-earnings-growth ratio of 0.47 and a beta of 0.75. The company has a quick ratio of 1.23, a current ratio of 2.91 and a debt-to-equity ratio of 2.67. The stock has a fifty day moving average of $23.40 and a 200-day moving average of $22.09.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a return on equity of 30.51% and a net margin of 2.68%. The business had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. Equities analysts anticipate that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.
Phibro Animal Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th were given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.71%. The ex-dividend date was Wednesday, June 4th. Phibro Animal Health's dividend payout ratio is presently 61.54%.
Institutional Trading of Phibro Animal Health
Hedge funds and other institutional investors have recently bought and sold shares of the business. Sterling Capital Management LLC boosted its position in shares of Phibro Animal Health by 2.4% during the 4th quarter. Sterling Capital Management LLC now owns 18,762 shares of the company's stock worth $394,000 after acquiring an additional 448 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Phibro Animal Health by 4.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,164 shares of the company's stock valued at $260,000 after purchasing an additional 546 shares during the last quarter. Algert Global LLC raised its holdings in Phibro Animal Health by 1.4% during the first quarter. Algert Global LLC now owns 97,612 shares of the company's stock worth $2,085,000 after purchasing an additional 1,340 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Phibro Animal Health during the fourth quarter worth approximately $29,000. Finally, National Bank of Canada FI purchased a new stake in shares of Phibro Animal Health during the 1st quarter worth approximately $30,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.
About Phibro Animal Health
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
See Also
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
